Reviewing the Evidence for Using Continuous Subcutaneous Metoclopramide and Ondansetron To Treat Nausea & Vomiting During Pregnancy
More like this
- Were Some Studies Overlooked In Nausea and Vomiting Paper?
- Measuring Outpatient Outcomes of Emesis and Nausea Management in Pregnant Women
- Nausea and Vomiting of Pregnancy: Cost Effective Pharmacologic Treatments
- Drug Dealing in the Doctor's Office, or Who's the Criminal, Who's the Victim?
- Transdermal Patch Tailors Antinausea Treatment
|Customer Analytics & Engagement in Health Insurance||Chicago||December 4–5, 2014|
|Pharmaceutical and Biotech Clinical Quality Assurance Conference||Alexandria, VA||December 4–5, 2014|
|6th Semi-Annual Diagnostic Coverage and Reimbursement Conference||Boston||December 4–5, 2014|
|9th Semi-Annual Medical Device Coverage and Reimbursement Conference||San Diego||December 5, 2014|
|8th Annual Medical Device Clinical Trials Conference||Chicago||December 8–9, 2014|
|HealthIMPACT Southeast||Tampa, FL||January 23, 2015|